Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MYH7///MYH6 |
| Upstream (Parents) |
|---|
| (<<) ACTA1 → MYH7///MYH6 |
| (<<) TNNI1 → MYH7///MYH6 |
| Downstream (Children) |
|---|
| MYH7///MYH6 → CA3 (>>) |
| MYH7///MYH6 → ACTN3 (>>) |
| MYH7///MYH6 → TNNC1 (>>) |
| MYH7///MYH6 → ACTA1 (>>) |
| MYH7///MYH6 → TRDN (>>) |
| MYH7///MYH6 → TPSG1 (>>) |
| MYH7///MYH6 → TNNT1 (>>) |
| MYH7///MYH6 → TCAP (>>) |
| MYH7///MYH6 → SYNPO2L (>>) |
| MYH7///MYH6 → MB (>>) |
| MYH7///MYH6 → TNNI1 (>>) |
| MYH7///MYH6 → PYGM (>>) |
| MYH7///MYH6 → EEF1A2 (>>) |
| MYH7///MYH6 → ACTN2 (>>) |
| MYH7///MYH6 → PGAM2 (>>) |
| MYH7///MYH6 → SLN (>>) |
| MYH7///MYH6 → CACNA1S (>>) |
